切开复位内固定治疗骨盆桶柄样Tilt骨折

目的探讨骨盆桶柄样Tilt骨折手术治疗方法。方法切开复位内固定治疗52例骨盆桶柄样Tilt骨折。前骨盆经Plan—nenstiel入路固定9例，Pfannenstiel入路结合部分髂腹般沟入路固定43例。37例行骨盆重建钢板固定，骨盆重建钢板固定结合耻骨上支髓内螺钉固定9例，6例2块骨盆重建钢板固定。后环37例经患侧髂嵴入路以骨盆重建钢板固定。8例骶骨骨折行骶髂关节螺钉固定。7例未行后骨盆固定。结果平均随访18个月。全部骨性愈合，无下肢不等长，骨盆畸形基本纠正。按Majeed疗效评定标准优良率为93．8％。结论通过前后联合入路，切开复位治疗骨盆桶柄样Tilt骨折疗效满意，并可防止远近期并发症的发生。     

肿瘤坏死因子及中性粒细胞在脊髓继发性损伤中的作用

目的 探讨炎性反应对脊髓损伤细胞凋亡的影响及其作用机制。方法 健康Wistar大鼠48只。随机分为2组，实验组与对照组。采用Allen法挫伤大鼠T10节段脊髓，于术后1、8h和1、2、3、7d取材。检测肿瘤坏死因子（TNF）与髓过氧化物酶水平的变化。结果 实验组肿瘤坏死因子与髓过氧化物酶水平均明显升高（P〈0．01）。结论 中性粒细胞及TNF-α参与了脊髓继发性损伤，并可能是触发迟发性神经元凋亡的重要因素之一。     

皮肤穿支血管的解剖学研究

目的：对全身皮肤血管区域进行定性和定量分析，确定全身皮肤穿支血管的位置、数量、口径、穿支蒂的长度、类型、来源血管以及穿支所供应皮肤的面积，为穿支皮瓣提供血管解剖基础。方法：选用10具新鲜尸体，采用改良氧化铅一明胶灌注技术进行动脉灌注。将每个口径大于0．5mm的穿支血管进行解剖并记录。拍摄X线片以显示皮肤内血管的形态和分布。定量数据分析包括全身各部位的穿支血管的数量、口径、类型及其供应区域的面积。结果：发现全身128支起源血管发出440支穿支供应皮肤。其中肌皮穿支与肌间隔穿支之比为3：2。穿支平均直径为0．7mm。穿支血管的分布规律如下：①躯干皮肤的血供主要来自肌皮穿支，这些穿支在皮肤内的走行距离和分布范围大于肢体皮肤的穿支。②肢体皮肤的血供主要来自肌间隙穿支血管，主要分布在深筋膜表面，皮神经和浅静脉周围穿支之间形成链式血管吻合。③单位面积的穿支数量与皮肤的移动程度成反比，穿支的口径大小和穿支在皮肤内走行距离与皮肤移动度成正比，与穿支的供应面积成正比。结论：本研究提供详细的皮肤穿支血管解剖数据，为临床设计应用穿支皮瓣提供解剖学依据。     

CircCDR1as Suppresses Bone Microvascular Endothelial Cell Activity and Angiogenesis Through Targeting miR‐135b/ FIH‐1 Axis

ObjectiveThe current study investigated the role of CircCDR1as on angiogenesis of bone microvascular endothelial cells (BMECs) isolated from non‐traumatic ONFH.MethodsForty corticosteroid‐induced ONFH patients received THA were enrolled in our study. Expressions of CircCDR1as, miR‐135b, and FIH‐1 were detected by qRT‐PCR in affected necrosis tissue and non‐affected normal tissue. Bone microvascular endothelial cells (BMEC) were isolated from six patients and treated with 0.1 mg/mL hydrocortisone to establish a GC‐damaged model of BMECs. Circ CDR1as plasmid and miR‐135b mimic were transfected into BMECs. BMEC proliferation was assessed using MTT assays. The migration ability of cells was detected by scratch‐wound assays. Matrigel assay was performed to detect angiogenesis in vitro. Western blot assay was used to detect HIF‐1α, VEGF, and FIH‐1 expressions. FISH, RNA pull down, RIP, and luciferase assay were carried out to determine the interaction of CircCDR1as, miR‐135b, and FIH‐1.ResultsCircCDR1as was upregulated(2.02 ± 0.30 vs. 1.00 ± 0.10,P < 0.001) whereas miR‐135b was downregulated (0.55 ± 0.12 vs. 1.00 ± 0.10,P < 0.001) in affected tissues than in non‐affected tissues. Expression of CircCDR1as and FIH‐1 were negatively associated with miR‐135b in affected tissues (CircCDR1as with miR‐135b: r = −0.506, P < 0.001; FIH‐1 with miR‐135b r = −0.510, P < 0.001). Total blood tubule density was increased when CircCDR1as was silenced compared with NC (P < 0.01 vs. NC). The number of migrated BMECs were significantly increased in CircCDR1as silencing group compared with NC group (P < 0.05 vs. NC). In addition, CircCDR1as plasmids transfection increased the protein expressions of FIH‐1 (P < 0.05 vs. NC) and reduced the HIF‐1α as well as VEGF expression compared with NC group (P < 0.05 vs. NC). FISH, RNA pull down, RIP, and luciferase assay identified that FIH‐1 was a target of miR‐135b and could be modulated by CircCDR1as.ConclusionCircCDR1as decreases angiogenesis and proliferation of BMECs by sponging miR‐135b and upregulate FIH‐1.     

蛋白酶体抑制剂Z-LLL-CHO对人骨肉瘤细胞株MG-63作用的体外研究

目的　探讨蛋白酶体抑制剂Z LLL CHO对人骨肉瘤细胞株MG 63的作用 ,并探讨其作用机制。方法　将不同浓度的Z LLL CHO作用于骨肉瘤细胞株MG 63 ,采用荧光显微镜观察细胞形态改变、电镜观察细胞超微结构变化、MTT法检测细胞增殖活力、琼脂糖凝胶电泳检测细胞凋亡、流式细胞仪分析细胞凋亡率及细胞周期改变。结果　Z LLL CHO可有效抑制MG 63细胞株的生长 ,并诱导细胞发生凋亡。凋亡细胞表现为浓染致密的颗粒块状荧光 ,胞核固缩、染色质凝聚并边缘化 ,DNA呈“阶梯状”排列的条带。流式细胞仪分析显示 ,Z LLL CHO在 1.0 μmol/L作用 2 4h、3 6h、48h后 ,细胞凋亡率分别为 5 .4%、2 0 .5 %、5 2 .7%。随药物浓度增高及作用时间延长 ,细胞周期被阻滞于G2 /M期。结论　蛋白酶体抑制剂Z LLL CHO可有效抑制人骨肉瘤MG 63细胞株的生长增殖 ,阻滞细胞周期及诱导细胞凋亡可能起重要作用。     

The mediating role of Mediterranean diet on the association between Lp(a) levels and cardiovascular disease risk: A 10-year follow-up of the ATTICA study

ObjectiveΤo evaluate the combined modifying effect of dietary habits and/or features of healthy aging, on the lipoprotein-alpha [Lp(a)] and CVD risk association.Design and MethodsΤhe ATTICA is a prospective, population-based study conducted in the greater metropolitan area of Athens (Attica, Greece). During 2001–2002, 3042 CVD-free adults (men/women: 1514/1528, 18–89 years) agreed to participate. In 2011–2012, the 10-year study follow-up was performed, recording the fatal/non-fatal CVD incidence in 2020 participants (mean follow-up: 8.41 years). Various bio-clinical characteristics [including low-density lipoprotein-cholesterol (LDL-C), Lp(a)] were derived through standard procedures. Dietary habits were assessed through the MedDietScore (an index assessing adherence to the Mediterranean diet with theoretical range 0–55). A validated successful aging index (SAI), ranging from 0 to 10, was used to assess healthy aging.ResultsLp(a) levels were positively associated with 10-year CVD incidence (Hazard Ratio: 1.02, 95%CI 1.01–1.04); when MedDietScore was included in the model the observed association between Lp(a) levels and CVD risk disappeared (1.00, 95%CI 0.98–1.01), and a mediating effect of Mediterranean diet was revealed (Sobel's test p < 0.001). In the model that included both MedDietScore and SAI, the interaction effect of these two features on 10-year CVD risk was highly protective (p < 0.001), whereas the association between Lp(a) levels and CVD risk was further mediated (Sobel's test p < 0.001).ConclusionsAdherence to a healthy dietary pattern, like the Mediterranean diet seems to mediate the association between Lp(a) with CVD risk whereas a successful aging together with a healthy diet seems to further explain the previously mentioned association.     

髋部骨折术后物理措施预防血栓形成的有效性分析

目的探讨髋部骨折围手术期物理措施预防血栓形成的有效性和安全性。方法把96例符合条件的患者分为A和B两组,A组术后应用物理措施预防血栓形成,B组术后应用低分子肝素钙预防血栓形成,通过对比两组深静脉和肺栓塞的发生率及出血性并发症的发生率,比较两组治疗措施的效果。结果 A组48例物理措施预防血栓形成的患者血栓形成的发生率为8.33%,出血性并发症的发生率为2.08%;B组48例应用低分子肝素钙血栓形成的发生率为6.25%,出血性并发症的发生率为4.17%。结论在髋关节骨折术后中单独应用物理措施预防血栓形成的效果并不比单独应用低分子肝素差。